Literature DB >> 6468479

The pharmacokinetics of alcohol in human breath, venous and arterial blood after oral ingestion.

E Martin, W Moll, P Schmid, L Dettli.   

Abstract

The concentration-time profile of ethanol in breath air (AAC), arterial (ABAC) and venous blood (VBAC) of human volunteers was studied after four different oral doses of absolute alcohol--0.5, 0.75, 1.0, and 1.25 g/kg body weight. Seventy-eight single dose experiments were carried out in 42 subjects. In all 78 studies AAC was measured and VBAC was estimated simultaneously in blood collected from a cubital vein of 36 volunteers. Arterial blood, too, was collected from 8 subjects from a catheter in a brachial artery. All blood alcohol concentrations were analysed independently by gas chromatography (GLC) and an enzymatic (ADH) method. A one-compartment open model with first order absorption and pseudo-zero-order elimination was employed to calculate the pharmacokinetic parameters. The average values for the first order absorption rate constant (ka) ranged from 2.2 to 3.1, from 2.4 to 2.6 and from 1.0 to 1.7 h-1 for ACC, ABAC and VBAC, respectively. The pseudo-zero-order elimination rate constant (beta) was 0.17 to 0.18, 0.21 to 0.22 and 0.26 to 0.27 g X 1(-1) X h-1, respectively. During absorption ABAC tended to be higher than VBAC, peaking at a higher level (Cmax) and with a shorter time to peak (tmax) until an arterio-venous concentration equilibrium was reached, whereafter VBAC remained above ABAC. Although there was a close relationship between AAC, ABAC and VBAC during elimination, AAC closely followed the pattern of ABAC during absorption and tended to deviate from VBAC. AAC, therefore, is a much better predictor of ABAC during absorption than VBAC.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6468479     DOI: 10.1007/bf00543496

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  22 in total

Review 1.  Direct effects of ethanol on the nervous system.

Authors:  H Kalant
Journal:  Fed Proc       Date:  1975-09

2.  The kinetics of alcohol elimination in man.

Authors:  F LUNDQUIST; H WOLTHERS
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1958

3.  Concentrations of ethanol in two segments of the vascular system.

Authors:  A J Sedman; P K Wilkinson; J G Wagner
Journal:  J Forensic Sci       Date:  1976-04       Impact factor: 1.832

4.  Elimination of alcohol from human blood.

Authors:  J G Wagner; P K Wilkinson; A J Sedman; D R Kay; D J Weidler
Journal:  J Pharm Sci       Date:  1976-01       Impact factor: 3.534

5.  [On the course of alcoholic intoxication with special reference to pharmacopsychological factors during the resorption phase in addicts].

Authors:  F BSCHOR
Journal:  Dtsch Z Gesamte Gerichtl Med       Date:  1951

6.  Genetic and environmental factors affecting ethanol metabolism in man.

Authors:  E S Vesell; J G Page; G T Passananti
Journal:  Clin Pharmacol Ther       Date:  1971 Mar-Apr       Impact factor: 6.875

7.  The precision and accuracy of a gas chromatograph intoximeter breath alcohol device part II--in-vivo experiments.

Authors:  A W Jones
Journal:  J Forensic Sci Soc       Date:  1978 Jan-Apr

8.  The metabolism and pharmacokinetics of alcohol in man.

Authors:  P W Mullen
Journal:  J Forensic Sci Soc       Date:  1977-01

9.  Arterial-venous blood alcohol concentration gradients.

Authors:  P K Wilkinson; J L Rheingold
Journal:  J Pharmacokinet Biopharm       Date:  1981-06

10.  Evaluation of methods for estimating population pharmacokinetics parameters. I. Michaelis-Menten model: routine clinical pharmacokinetic data.

Authors:  L B Sheiner; S L Beal
Journal:  J Pharmacokinet Biopharm       Date:  1980-12
View more
  17 in total

1.  Concentration dependency of the BAC/BrAC (blood alcohol concentration/breath alcohol concentration) conversion factor during the linear elimination phase.

Authors:  H T Haffner; M Graw; A Dettling; G Schmitt; A Schuff
Journal:  Int J Legal Med       Date:  2003-07-05       Impact factor: 2.686

2.  ADH single nucleotide polymorphism associations with alcohol metabolism in vivo.

Authors:  Andrew J Birley; Michael R James; Peter A Dickson; Grant W Montgomery; Andrew C Heath; Nicholas G Martin; John B Whitfield
Journal:  Hum Mol Genet       Date:  2009-02-04       Impact factor: 6.150

Review 3.  Role of variability in explaining ethanol pharmacokinetics: research and forensic applications.

Authors:  Ake Norberg; A Wayne Jones; Robert G Hahn; Johan L Gabrielsson
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

Review 4.  Inhalation of Alcohol Vapor: Measurement and Implications.

Authors:  Robert Ross MacLean; Gerald W Valentine; Peter I Jatlow; Mehmet Sofuoglu
Journal:  Alcohol Clin Exp Res       Date:  2017-01-05       Impact factor: 3.455

5.  Problems and pitfalls in estimating average pharmacokinetic parameters.

Authors:  E Martin; W Moll; P Schmid; L Dettli
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

6.  Two components of the human alcohol electro-oculogram.

Authors:  Janet E Wolf; Geoffrey B Arden
Journal:  Doc Ophthalmol       Date:  2004-09       Impact factor: 2.379

Review 7.  Clinical pharmacokinetics of ethanol.

Authors:  N H Holford
Journal:  Clin Pharmacokinet       Date:  1987-11       Impact factor: 6.447

8.  Time Delays in Transdermal Alcohol Concentrations Relative to Breath Alcohol Concentrations.

Authors:  Tara E Karns-Wright; John D Roache; Nathalie Hill-Kapturczak; Yuanyuan Liang; Jillian Mullen; Donald M Dougherty
Journal:  Alcohol Alcohol       Date:  2016-08-13       Impact factor: 2.826

9.  Ethanol kinetics: extent of error in back extrapolation procedures.

Authors:  Y al-Lanqawi; T A Moreland; J McEwen; F Halliday; C J Durnin; I H Stevenson
Journal:  Br J Clin Pharmacol       Date:  1992-10       Impact factor: 4.335

10.  Comparison of spectroscopically measured tissue alcohol concentration to blood and breath alcohol measurements.

Authors:  Trent D Ridder; Benjamin J Ver Steeg; Bentley D Laaksonen
Journal:  J Biomed Opt       Date:  2009 Sep-Oct       Impact factor: 3.170

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.